Bobek M, Kuhar S, Bloch A
J Med Chem. 1979 May;22(5):592-4. doi: 10.1021/jm00191a028.
5-Fluoro-1,3-oxazine-2,6(3H)-dione (3-oxa-FU) was synthesized by reacting 3-oxauracil with fluoroxytrifluoromethane and decomposing the adduct in the presence of a catalytic amount of Et3N. 5-Methyl-1,3-oxazine-2,6(3H)-dione (3-oxathymine) was prepared by polyphosphoric acid catalyzed ring closure of beta-(N-ethoxycarbonylamino)-2-methacrylic acid and by treatment of citraconimide with sodium hypochlorite. As determined in vitro, 3-oxa-FU was markedly inhibitory to S. faecium (ID50 = 9 X 10(-8) M) and E. coli (ID50 = 1 X 10(-7) M) but was less active against leukemia L-1210 cells (ID50 = 1 X 10(-5) M). At 1 x 10(-4) M, 3-oxathymine was inactive in these cell systems. Inhibition of the growth of S. faecium by 3-oxa-FU was reversed competitively by the natural pyrimidines. The relatively rapid hydrolysis of the compounds in the growth media is a major factor in determining their biological effectiveness.
5-氟-1,3-恶嗪-2,6(3H)-二酮(3-氧杂氟尿嘧啶)通过使3-氧杂尿嘧啶与氟代三氟甲烷反应,并在催化量的三乙胺存在下分解加合物来合成。5-甲基-1,3-恶嗪-2,6(3H)-二酮(3-氧杂胸腺嘧啶)通过β-(N-乙氧羰基氨基)-2-甲基丙烯酸的多磷酸催化闭环以及用次氯酸钠处理柠康酰亚胺来制备。体外测定表明,3-氧杂氟尿嘧啶对粪肠球菌(ID50 = 9×10^(-8) M)和大肠杆菌(ID50 = 1×10^(-7) M)有显著抑制作用,但对白血病L-1210细胞的活性较低(ID50 = 1×10^(-5) M)。在1×10^(-4) M时,3-氧杂胸腺嘧啶在这些细胞系统中无活性。3-氧杂氟尿嘧啶对粪肠球菌生长的抑制作用可被天然嘧啶竞争性逆转。这些化合物在生长培养基中相对快速的水解是决定其生物学有效性的主要因素。